These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29170165)

  • 1. Philip Morris International introduces new heat-not-burn product, IQOS, in South Korea.
    Kim M
    Tob Control; 2018 Jul; 27(e1):e76-e78. PubMed ID: 29170165
    [No Abstract]   [Full Text] [Related]  

  • 2. BAT(NZ) draws on cigarette marketing tactics to launch Vype in New Zealand.
    Hoek J; Freeman B
    Tob Control; 2019 Dec; 28(e2):e162-e163. PubMed ID: 31315965
    [No Abstract]   [Full Text] [Related]  

  • 3. British American Tobacco (BAT) and retail merchandising: Vype e-cigarette promotion in Ontario, Canada.
    Dewhirst T
    Tob Control; 2019 Dec; 28(e2):e164-e167. PubMed ID: 31249103
    [No Abstract]   [Full Text] [Related]  

  • 4. Marketing IQOS in a dark market.
    Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
    Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philip Morris International: a New Year's resolution.
    Moodie C; Hammond D; Bauld L
    Tob Control; 2018 Jul; 27(e1):e79-e80. PubMed ID: 29540559
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly increasing promotional expenditures for e-cigarettes.
    Kornfield R; Huang J; Vera L; Emery SL
    Tob Control; 2015 Mar; 24(2):110-1. PubMed ID: 24789603
    [No Abstract]   [Full Text] [Related]  

  • 7. Philip Morris International: money over morality?
    The Lancet
    Lancet; 2019 Aug; 394(10200):709. PubMed ID: 31478485
    [No Abstract]   [Full Text] [Related]  

  • 8. Return of cartoon to market e-cigarette-related products.
    Allem JP; Cruz TB; Unger JB; Toruno R; Herrera J; Kirkpatrick MG
    Tob Control; 2019 Sep; 28(5):555-557. PubMed ID: 30049688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Package size matters: tobacco packaging, retail merchandising and its influence on trial and impulse sales.
    Dewhirst T
    Tob Control; 2018 Sep; 27(5):600-602. PubMed ID: 29026000
    [No Abstract]   [Full Text] [Related]  

  • 10. Heated tobacco products likely appeal to adolescents and young adults.
    McKelvey K; Popova L; Kim M; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s41-s47. PubMed ID: 30352843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic cigarette marketing tactics in mainland China.
    Jiang N; Ho SY; Lam TH
    Tob Control; 2017 Mar; 26(2):230-232. PubMed ID: 27071732
    [No Abstract]   [Full Text] [Related]  

  • 12. World Vapor Expo 2017: e-cigarette marketing tactics.
    Ben Taleb Z; Ebrahimi Kalan M
    Tob Control; 2018 Jul; 27(e1):e81-e82. PubMed ID: 29540557
    [No Abstract]   [Full Text] [Related]  

  • 13. Electronic cigarette retailers use Pokémon Go to market products.
    Kirkpatrick MG; Cruz TB; Goldenson NI; Allem JP; Chu KH; Pentz MA; Unger JB
    Tob Control; 2017 Dec; 26(e2):e145-e147. PubMed ID: 28044010
    [No Abstract]   [Full Text] [Related]  

  • 14. Point-of-Sale E-cigarette Advertising Among Tobacco Stores.
    Wan N; Siahpush M; Shaikh RA; McCarthy M; Ramos A; Correa A
    J Community Health; 2017 Dec; 42(6):1179-1186. PubMed ID: 28488037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cigarette marketing targeted to youth in South Korea.
    Lee WB
    Tob Control; 2017 Dec; 26(e2):e140-e144. PubMed ID: 28062581
    [No Abstract]   [Full Text] [Related]  

  • 17. How Philip Morris built Marlboro into a global brand for young adults: implications for international tobacco control.
    Hafez N; Ling PM
    Tob Control; 2005 Aug; 14(4):262-71. PubMed ID: 16046690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revolution or redux? Assessing IQOS through a precursor product.
    Elias J; Dutra LM; St Helen G; Ling PM
    Tob Control; 2018 Nov; 27(Suppl 1):s102-s110. PubMed ID: 30305324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQOS labelling will mislead consumers.
    McKelvey K; Popova L; Kim M; Lempert LK; Chaffee BW; Vijayaraghavan M; Ling P; Halpern-Felsher B
    Tob Control; 2018 Nov; 27(Suppl 1):s48-s54. PubMed ID: 30158208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavored tobacco to E-cigarette's: How the tobacco industry sustains its product flow.
    Raj AT; Patil S; Gupta AA; Suveetha G
    Oral Oncol; 2018 Oct; 85():110. PubMed ID: 30087003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.